Dr. Muntner has an extensive bibliography in clinical and population hypertension, including over 500 peer-reviewed journal articles. Consultancy: Amgen Grant/research support: Amgen and National Institutes of Health Roberto Pecoits-Filho, MD, PhD, FASN, FACP, is a senior research sci- entist at Arbor Research Collaborative for Health in Ann Arbor, MI, USA, and a professor of medicine at the Ponti cal Catholic University of Paran in Curi- tiba, Brazil. As a clinician, he has broad activities in internal medicine and nephrology based at the university- af liated hospitals, where he was chief of the Department of Internal Medicine between 2010 and 2016, and the director of the residency program in nephrology from 2013 to 2016. Dr. Pecoits-Filho is the principal investigator for CKDOPPS, a multinational study on practice patterns and outcomes in CKD, and acts as a scien- ti c leader for clinical trials in nephrology with George Clinical, Sydney, Australia. Dr. Pecoits-Filho received his medical degree and trained in internal medicine and nephrology in Curitiba, Brazil, before completing a research nephrology fellowship at the University of Missouri, Columbia, MO, USA, and a PhD from the University of Sao Paulo, Brazil. He was a visiting scholar for extended periods at the Karolinska Institute in Sweden and the George Institute in Australia. He has participated as a principal investigator, regional leader, and on steering com- mittees in multinational clinical trials. Dr. Pecoits-Filho served as a member of the Executive Committee of the ISN (2017 2019), the SONG Initiative (2017 present), and KDIGO (2016 2018). Consultancy: Akebia, AstraZeneca, Fresenius Medical Care, and Novo Nordisk Grant/research support: Fresenius Medical Care* Speaker bureaus: AstraZeneca and Novo Nordisk *Monies paid to institution. 